Uji klinis Migrain di Georgia
9 studi untuk Migrain mencari peserta di lokasi di Georgia.
Kota di Georgia
Teks studi resmi (Bahasa Inggris)
Study of EVO756 in Adults With Migraine
- Clinical Integrative Research Center of Atlanta, Atlanta
- Accel Research Site-Decatur-Alcanza, Decatur
Menerima pesertaFase 2
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07616128A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Coastal Heritage Clinical Research, Hinesville
Menerima pesertaFase 1
Usia 6 hingga 11 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Clinical Trial Office, Augusta
- Augusta University, Augusta
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05156398Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- CenExel iResearch, LLC, Decatur
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- CenExel iResearch, LLC, Decatur
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT04649242Responding With Evidence and Access for Childhood Headaches
- Clinical Integrative Research Center of Atlanta, Inc, Atlanta
Menerima peserta
Usia 10 hingga 17 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05889624Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Rare Disease Research /ID# 231046, Atlanta
- Clinical Integrative Research Center of Atlanta (CIRCA) /ID# 231134, Atlanta
- Coastal Georgia Child Neurology /ID# 231409, Brunswick
- dan 1 lainnya
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05125302A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
- Vista Clinical Research, Newnan
Menerima peserta
Usia 22 hingga 84 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07719608A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- DelRicht Research, Atlanta
- Drug Studies America, Marietta
- Sleep Care Research Institute d/b/a Clinical Research Atlanta-Stockbridge, Stockbridge
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07645924Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.